Pharma Mar, S.A. (BME:PHM)
Spain · Delayed Price · Currency is EUR 96.65
-0.20 (-0.21%)
Apr 28, 2026, 2:48 PM CET
Pharma Mar Market Cap
Pharma Mar has a market cap or net worth of €1.68 billion as of April 28, 2026. Its market cap has increased by 25.30% in one year.
Market Cap
1.68B
Enterprise Value
1.56B
Revenue
221.39M
Ranking
n/a
PE Ratio
22.52
Stock Price
€96.65
Market Cap Chart
Since November 2, 2015, Pharma Mar's market cap has decreased from 1.80B to 1.68B, a decrease of -6.55%. That is a compound annual growth rate of -0.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.68B | 30.43% |
| Dec 31, 2025 | 1.29B | -7.20% |
| Dec 31, 2024 | 1.39B | 88.09% |
| Dec 29, 2023 | 738.49M | -36.23% |
| Dec 30, 2022 | 1.16B | 12.13% |
| Dec 30, 2021 | 1.03B | -21.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.58B |
| Laboratorios Farmaceuticos Rovi | 4.15B |
| Almirall | 2.73B |
| Faes Farma | 1.49B |
| Clínica Baviera | 832.96M |
| Prim, S.A. | 225.43M |
| Atrys Health | 220.51M |
| Laboratorio Reig Jofre | 217.37M |